Unfortunately, this is still a very common problem. Although the information that oral bisphosphonates should likely be limited to 5 years duration has been available for many years, my large orthopaedic practice continues to see 2-4 atypical femur fractures per month and often the patient has been ...

I generally agree with what’s been stated. If a patient post, AFF does not have risk factors for osteoporosis and has a normal bone density, they do not need further treatment. However, if a patient does remain a steel product despite the AFF then additional treatment is needed. Longitudinal s...